Shockwave Medical (SWAV) Tops Q2 EPS by 6c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Shockwave Medical Reports Second Quarter 2020 Financial Results
August 11, 2020 4:06 PM EDTSANTA CLARA, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended June 30, 2020.
Recent Highlights
Recognized revenue of $10.3 million for the second quarter of 2020, representing a 3% increase over the second quarter of 2019Completed enrolment in the CAD III pivotal study of IVL for coronary use in the United StatesCompleted enrolment in... More